MAK-683

N/A

Report date: 2024/11/03 20:00:07
NME

Base Information

Drug NameMAK-683
Drug Alias NameMAK-683
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolycomb protein EED inhibitors
TargetsPolycomb protein EED
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantOvarian NeoplasmsStomach Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgChina Novartis Institutes For Biomedical Research Co Ltd
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-ResistantOvarian NeoplasmsStomach Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A